Pill Identifier App

Vetropolycin Ophthalmic Ointment

This page contains information on Vetropolycin Ophthalmic Ointment for veterinary use.
The information provided typically includes the following:
  • Vetropolycin Ophthalmic Ointment Indications
  • Warnings and cautions for Vetropolycin Ophthalmic Ointment
  • Direction and dosage information for Vetropolycin Ophthalmic Ointment

Vetropolycin Ophthalmic Ointment

This treatment applies to the following species:
Manufacturer: Dechra

bacitracin-neomycin-polymyxin veterinary ophthalmic ointment


NADA # 065-016. Approved by FDA.


Each gram contains Bacitracin Zinc 400 units, Neomycin Sulfate 5 mg (equivalent to 3.5 mg of neomycin base), Polymyxin B Sulfate 10,000 units, in a base of White Petrolatum and Mineral Oil.


The three antibiotics present in Vetropolycin® (bacitracin-neomycin-polymyxin) veterinary ophthalmic ointment provide a broad spectrum of activity against the gram-positive and gram-negative bacteria commonly involved in superficial infections of the eyelid and conjunctiva. Bacitracin is effective against gram-positive bacteria including hemolytic and non-hemolytic Streptococci and Staphylococci. Resistant strains rarely develop. Neomycin is effective against both gram-positive and gram-negative bacteria including Staphylococci, Escherichia coli and Haemophilus influenzae and many strains of Proteus and Pseudomonas. Polymyxin B is bactericidal to gram-negative bacteria especially Pseudomonas. No resistant strains have been found to develop in vivo.

Vetropolycin Ophthalmic Ointment Indications

In the treatment of superficial bacterial infections of the eyelid and conjunctiva in dogs and cats when due to organisms susceptible to the antibiotics contained in the ointment. Laboratory tests should be conducted including in vitro culturing and susceptibility tests on samples collected prior to treatment.


Sensitivity to Vetropolycin® (bacitracin-neomycin-polymyxin) veterinary ophthalmic ointment is rare; however, if a reaction occurs, discontinue use of the preparation. As with any antibiotic preparation, prolonged use may result in the overgrowth of nonsusceptible organisms including fungi. Appropriate measures should be taken if this occurs. If infection does not respond to treatment in two or three days, the diagnosis and therapy should be re-evaluated.

Care should be taken not to contaminate the applicator tip of the tube during application of the preparation. Do not allow the applicator tip to come in contact with any tissue.

Adverse Reactions

Itching, burning or inflammation may occur in animals sensitive to the product. Discontinue use in such cases.

Dosage and Administration

Apply a thin film over the cornea three or four times daily in dogs and cats. The area should be properly cleansed prior to the use of Vetropolycin® (bacitracin-neomycin-polymyxin) veterinary ophthalmic ointment. Foreign bodies, crusted exudates, and debris should be carefully removed.

Vetropolycin Ophthalmic Ointment Caution

Federal law restricts this drug to use by or on the order of a licensed veterinarian.

WARNING: Do not use this product as a pre-surgical ocular lubricant. Adverse reactions of ocular irritation and corneal ulceration have been reported in association with such use.

How Supplied

3.5 g (1/8 Oz) sterile tamper proof tubes, NDC 17033-028-38.

STORE AT 15°-25°C (59°-77°F).

MANUFACTURED FOR: Dechra Veterinary Products, Overland Park, KS 66211

I12838 DECHRA R7/07


NAC No.: 14590560

Telephone:   913-327-0015
Toll-Free:   866-933-2472
Fax:   913-327-0016
Website:   www.dechra-us.com
Every effort has been made to ensure the accuracy of the Vetropolycin Ophthalmic Ointment information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2015 North American Compendiums. Updated: 2014-12-03